This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

KNCV Tuberculosis Foundation Honors USAID For Eminence And Leadership In Global Fight Against Tuberculosis

WASHINGTON, March 21, 2013 /PRNewswire/ --

Today, on its 110th anniversary, KNCV Tuberculosis Foundation has honored the  U.S.  Agency for International Development (USAID) for its exceptional dedication and wise leadership in the worldwide fight against tuberculosis (TB).

Gerdy Schippers, Director of KNCV Tuberculosis Foundation:

"On this occasion we proudly recognize the USA's tremendous contribution towards winning the battle against tuberculosis. We have now set the stage for a healthy future in which we can eliminate this persistent disease by building on the achievements so far."

Dr. Ariel Pablos-Mendez, Assistant Administrator for Global Health, accepted the "Award for Eminence in TB Control" on behalf of USAID during a luncheon ceremony at the residence of the Dutch Ambassador in Washington D.C.. Once every five years KNCV Tuberculosis Foundation bestows this prize on a person or organization who has made an extraordinary contribution to the worldwide fight against TB. Prior recipients of the Award have been The National Tuberculosis Programs of Tanzania, Vietnam and Kenya.  

Gerdy Schippers expressed deep appreciation for USAID's catalytic, innovative and leading role, noting the agency's enduring commitment and exemplary leadership in curbing the rise of TB. USAID has been KNCV Tuberculosis Foundation's most important partner in the past 13 years; and thanks to this longstanding partnership the organization has contributed to the diagnosis and treatment of some 24 million tuberculosis patients worldwide.

In the coming years KNCV Tuberculosis Foundation will continue to pursue its mission towards globally eliminating TB and will give priority to:

  • introducing and scaling-up new diagnostic technologies and shorter treatment regimens (expected soon);
  • reversing the rise of multidrug-resistant TB;
  • working in close partnership with organizations fighting HIV/AIDS to increase access to integrated care for both diseases;
  • making a "shift to thrift" through sustainable planning and financing of TB programs, and by working with all tiers and disciplines of TB healthcare providers.

KNCV Tuberculosis Foundation is the principal international non-profit organization that is exclusively dedicated to and focused on fighting TB worldwide and to strengthening health systems against TB.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs